Drug Manufacturers - Specialty & Generic | Healthcare
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral. Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Market Cap
115765452800
Current Price
477.1
52 Week Range
422.0 - 721.0
Previous Close
494.5
Open
494.5
Sector
Healthcare
Address
Granules Tower, 15th Floor Botanical Garden Road Kondapur, Hyderabad, 500084, India
Phone
+91-40690-43500
Fax
+91-40231-15145
Website
https://www.granulesindia.com
Day Low
476.05
Day High
495.7
Dividend Yield
0.3
PE Ratio
23.08176
Earnings Per Share
20.67
Beta
0.092
EBITDA
9452359680
Book Value
153.236
EPS
23.5
Name | Title | Age | Year Born |
---|---|---|---|
Dr. Krishna Prasad Chigurupati B.Sc. | Chairman & MD | 70 | 1954 |
Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. | Joint MD, CEO & Additional Director | 61 | 1963 |
Ms. Priyanka Chigurupati | Head of Marketing & Executive Director | - | - |
Mr. Harsha Chigurupati BBA | Executive Director | 41 | 1983 |
Dr. P. N. Baskaran | President - Head API Manufacturing & Operations | - | - |
Mr. Sanjay Kumar | President and Chief Strategy & Sustainability Officer | - | - |
Dr. Rajesh Kapoor Ph.D. | President & Global Head of Quality | - | - |
Mr. Mukesh Surana | Chief Financial Officer | 43 | 1981 |
Dr. P. V. Srinivas | CTO and Head of R&D | 58 | 1966 |
Ms. Chaitanya Tummala | Company Secretary & Compliance Officer | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.